EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:757186 - crizanlizumab
| ChEBI ID | CHEBI:757186 |
| ChEBI Name | crizanlizumab |
| Stars | |
| Last Modified | 30 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Biological Role: | antiviral agent A substance that destroys or inhibits replication of viruses. |
| Applications: | anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. antifibrotic agent Any agent which acts to reduce fibrosis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| crizanlizumab (CHEBI:757186) has role anti-anaemic agent (CHEBI:75835) |
| crizanlizumab (CHEBI:757186) has role antifibrotic agent (CHEBI:233423) |
| crizanlizumab (CHEBI:757186) has role antiviral agent (CHEBI:22587) |
| crizanlizumab (CHEBI:757186) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| Crizanlizumab | ChEMBL |
| Crizanlizumab tmca | ChEMBL |
| Crizanlizumab-tmca | ChEMBL |
| NVP-LXI-262 | ChEMBL |
| NVP-LXI262 | ChEMBL |
| SEG-101 | ChEMBL |
| Brand Name | Source |
|---|---|
| Adakveo | ChEMBL |